Table 2. Adolescent hematological and biochemistry reference values (median and 95th-percentile) comparison between locally-established reference intervals for western Kenya versus reference values established from the Kisumu Incidence cohort study in western Kenya (2007–2010).
| Local interval (Age 13–17 years) [15] | This study (Age 16–17 years) | |||
|---|---|---|---|---|
| Parameter | Male | Female | Male | Female |
| RBC (10 6 Cells/μl) | 4.9 (4.1–5.8) | 4.7 (3.3–5.4) | 5.2 (4.3–6.4) | 4.9 (3.7–6.0) |
| Hb (g/dL) | 13.1(10.6–15.6) | 12.2 (8.1–14.2) | 14.2 (11.1–16.7) | 12.7 (7.5–14.8) |
| HCT (%) | 38.8 (29.3–48.1) | 35.6 (24.8–43.1) | 42.6 (33.7–49.7) | 38.0 (24.2–43.7) |
| MCV (fL) | 79 (62–92) | 78 (57–91) | 80.9 (66.2–91.5) | 79.0 (52.5–88.5) |
| PLT (10 3 cells/μl) | 224 (103–386) | 233 (134–439) | 215 (112–474) | 264 (126–448) |
| WBC(10 3 cells/μl) | 5.6 (3.3–8.3) | 5.2 (3.9–10.2) | 5.2 (3.6–9.1) | 6.0 (3.6–9.5) |
| Ne (10 3 cells/μl) | 1.9 (0.8–5.0) | 2.0 (1.1–3.1) | 2.2 (0.9–6.7) | 2.7 (1.3–5.8) |
| Ly (10 3 cells/μl) | 2.2 (1.0–4.2) | 2.2 (1.1–3.1) | 2.2 (1.4–3.4) | 2.5 (1.2–3.9) |
| Mo (10 3 cells/μl) | 0.5 (0.2–0.7) | 0.4 (0.2–0.7) | 0.4 (0.2–0.8) | 0.5 (0.2–1.1) |
| Eo (10 3 cells/μl) | 0.4 (0.1–1.8) | 0.4 (0.1–2.2) | 0.22 (0.03–1.64) | 0.24 (0.05–1.4) |
| Ba (10 3 cells/μl) | 0.04 (0.02–0.30) | 0.04 (0–0.10) | 0.04 (0.02–0.09) | 0.04 (0.02–0.11) |
| ALT (μ/L) | 20.5 (4.9–42.4) | 17.4 (4.2–65.3) | 16.4 (7.8–33.9) | 14.1 (5.7–32.5) |
| Creatinine (μmol/L) | 66.3 (49.6–103.7) | 64.5 (48.0–87.6) | 65 (39–89) | 51 (40–69) |
| BUN (mmol/L) | 2.5 (1.7–4.1) | 2.3 (1.2–4.8) | 2.7 (1.2–4.5) | 2.4 (1.2–4.2) |